PPCB Propanc Biopharma, Inc.
$0.92▼ -2.31%
Healthcare
Other
After hours
$0.90▼ -2.17%
Sep 11, 7:30 PM ET
Volume 224.9K
Avg Volume (10D) 738.0K
Key Metrics & Fundamentals
Market Cap
$2.10M
P/E Ratio
0.0
Div Yield
–%
52W Range
0.87 - 60.00
% vs 50 MA
-29.11%
% vs 200 MA
-82.47%
RSI-14
42.1
MACD Histogram
-0.0300
Beta (1Y vs SPY)
2.72
Free Cash Flow
-$1.14M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.44M
COGS
–
Operating Exp
$6.40M
Operating Income
-$6.40M
EBIT
-$6.40M
Pretax Income
-$6.36M
Net Income
-$6.36M
EPS (Diluted)
-7.00
Price & Volume History
Loading chart…
Recent News
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
GlobeNewswire · Sep 9, 2026 12:30 PM
BC-Most Active Stocks
Associated Press · Aug 27, 2026 2:30 PM
Propanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition
InvestorsHub · Aug 27, 2026 2:29 PM
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
GlobeNewswire · Aug 27, 2026 12:30 PM
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
GlobeNewswire · Aug 18, 2026 12:30 PM
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
GlobeNewswire · Aug 12, 2026 12:30 PM
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
GlobeNewswire · Aug 6, 2026 12:30 PM
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
GlobeNewswire · Aug 5, 2026 12:30 PM
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
GlobeNewswire · Jul 21, 2026 12:30 PM
Propanc Biopharma Signs MoU With Avance Clinical to Jointly Undertake Advanced Solid Tumors Study
MT Newswires · Jul 7, 2026 1:09 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PPCB's money flow as a full page
Social Sentiment
No Reddit posts found for PPCB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.